{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:30:04Z","timestamp":1762079404300},"reference-count":38,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ejim.2013.04.008","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T14:33:14Z","timestamp":1368714794000},"page":"324-332","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Decision making for oral anticoagulants in atrial fibrillation: The ATA-AF study"],"prefix":"10.1016","volume":"24","author":[{"given":"Gualberto","family":"Gussoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Di Pasquale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Vescovo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Gulizia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marino","family":"Scherillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Panuccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donata","family":"Lucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Nozzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianna","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Riva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concetta I.","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo P.","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2013.04.008_bb0005","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/0002-9149(90)90323-S","article-title":"Risk for systemic embolization of atrial fibrillation without mitral stenosis","volume":"65","author":"Cabin","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2013.04.008_bb0010","doi-asserted-by":"crossref","first-page":"e531S","DOI":"10.1378\/chest.11-2304","article-title":"Antithrombotic therapy for atrial fibrillation. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"You","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2013.04.008_bb0015","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation","volume":"31","author":"The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2013.04.008_bb0020","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation. The Framingham Study","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2013.04.008_bb0025","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2013.04.008_bb0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2013.04.008_bb0035","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/CIRCULATIONAHA.106.177292","volume":"114","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2013.04.008_bb0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cjca.2012.01.021","article-title":"Focused 2012 update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: recommendations for stroke prevention and rate\/rhythm control","volume":"28","author":"Skanes","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ejim.2013.04.008_bb0045","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomized controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2013.04.008_bb0050","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1160\/TH09-10-0746","article-title":"Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1","volume":"103","author":"Gorin","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.04.008_bb0055","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.04.008_bb0060","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","article-title":"The net clinical benefit of warfarin anticoagulation in atrial fibrillation","volume":"151","author":"Singer","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.04.008_bb0065","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries. The Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2013.04.008_bb0070","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2005.06.077","article-title":"Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation","volume":"46","author":"Waldo","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2013.04.008_bb0075","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/eurheartj\/ehl208","article-title":"Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation","volume":"27","author":"Monte","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2013.04.008_bb0080","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1160\/TH09-08-0525","article-title":"A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care","volume":"103","author":"Mazzaglia","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.04.008_bb0085","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in patients with atrial fibrillation: the EURO Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2013.04.008_bb0090","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study","volume":"58","author":"Fang","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2013.04.008_bb0095","article-title":"Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA-AF study","author":"Di Pasquale","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2013.04.008_bb0100","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ahj.2008.06.029","article-title":"Prevalence, clinical profile and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis","volume":"156","author":"Goto","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2013.04.008_bb0105","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/europace\/eun086","article-title":"Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world","volume":"10","author":"Meiltz","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2013.04.008_bb0110","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of oral anticoagulants in atrial fibrillation: a systematic review","volume":"123","author":"Ogilvie","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2013.04.008_bb0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2459\/JCM.0b013e328348e5ce","article-title":"Real-world management of atrial fibrillation in Internal Medicine: the FADOI \u201cFALP\u201d observational study","volume":"14","author":"Campanini","year":"2013","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.ejim.2013.04.008_bb0120","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ejim.2010.07.014","article-title":"Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to Internal Medicine wards","volume":"21","author":"Marcucci","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2013.04.008_bb0125","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1093\/eurheartj\/ehl015","article-title":"Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation","volume":"27","author":"Nieuwlaat","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2013.04.008_bb0130","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jacc.2009.04.091","article-title":"Quality of care for atrial fibrillation among patients hospitalized for heart failure","volume":"54","author":"Piccini","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2013.04.008_bb0135","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.amjmed.2009.11.015","article-title":"Are atrial fibrillation patients receiving warfarin in accordance with stroke risk?","volume":"123","author":"Zimetbaum","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2013.04.008_bb0140","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1160\/TH10-07-0491","article-title":"New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs","volume":"104","author":"Garcia","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.04.008_bb0145","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/CIRCULATIONAHA.110.007864","article-title":"Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation","volume":"124","author":"Poli","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2013.04.008_bb0150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(99)00489-1","article-title":"Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy","volume":"35","author":"Hart","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2013.04.008_bb0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1160\/TH08-05-0331","article-title":"Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis","volume":"100","author":"Lip","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.04.008_bb0160","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1160\/TH12-03-0175","article-title":"The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0\u20131: a nationwide cohort study","volume":"107","author":"Olesen","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.04.008_bb0165","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1160\/TH11-05-0364","article-title":"Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a \u2018real world\u2019 nationwide cohort study","volume":"106","author":"Olesen","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.04.008_bb0170","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.111.055079","article-title":"Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish Atrial Fibrillation Cohort Study","volume":"125","author":"Friberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2013.04.008_bb0175","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1161\/STROKEAHA.111.617886","article-title":"A new landscape for stroke prevention in atrial fibrillation: focus on new anticoagulants, antiarrhythmic drugs, and devices","volume":"42","author":"Banerjee","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2013.04.008_bb0180","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.04.008_bb0185","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.04.008_bb0190","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513001118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513001118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T18:08:08Z","timestamp":1563041288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620513001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0953620513001118"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2013.04.008","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decision making for oral anticoagulants in atrial fibrillation: The ATA-AF study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2013.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}